Shilajit for Energy and Fatigue After Menopause: The Mitochondrial Research

The fatigue that arrives with menopause is one of the most consistent and disruptive changes women describe, and one of the hardest to explain to anyone who has not experienced it. It does not feel like the tired that follows a long day or a night of poor sleep. It is a depletion that does not fully resolve with rest, a dimming of the reserve that used to carry through afternoons and evenings without effort.

Shilajit is not a stimulant and does not work like caffeine. What the research suggests it does instead is support the cellular machinery that actually produces energy: the mitochondria. The distinction between stimulating the stress system and supporting cellular energy production matters more than it might seem at first.

What menopause does to your energy

The energy drop that accompanies menopause has a biological explanation, and it runs through mitochondria.

Mitochondria are structures inside nearly every cell that convert food and oxygen into ATP, the molecule cells use for every function from muscle contraction to nerve signaling to immune response. The amount of ATP your cells can produce depends on how efficiently your mitochondria are working. When mitochondrial function declines, everything that runs on cellular energy declines with it.

Estrogen is deeply involved in mitochondrial function. Estrogen receptors are found on mitochondria throughout the body. Estrogen signaling supports the production of new mitochondria, a process called mitochondrial biogenesis, and protects existing mitochondria from oxidative damage. When estrogen signaling drops at menopause, mitochondrial function tends to drop with it. The cells can still produce ATP, but less of it, and less efficiently.

The result is the kind of fatigue women in menopause describe as different from any they experienced before. Not sleepiness. Not the tired that follows exertion. An underlying depletion that affects cognitive clarity, physical stamina, and recovery from ordinary effort. Understanding that it has a mitochondrial root points toward what might actually help.

How shilajit interacts with mitochondrial function

Shilajit contains fulvic acid, and one of fulvic acid's most studied properties is its role as an electron shuttle. Mitochondria produce ATP through a chain of electron transfers across proteins embedded in the inner mitochondrial membrane. When that chain runs efficiently, ATP production is high. When it runs inefficiently, due to oxidative damage or the depletion of electron carriers, ATP output falls and oxidative byproducts accumulate.

CoQ10 is one of the critical electron carriers in this chain. Fulvic acid appears to stabilize CoQ10 in its reduced, active form, helping it continue functioning as an electron shuttle under oxidative stress conditions. This is the molecular mechanism behind shilajit's long-standing classification as an adaptogen in the Ayurvedic tradition. An adaptogen supports the body's capacity to respond to stress rather than providing a direct stimulant effect.

This is mechanically different from caffeine or any stimulant. A stimulant works by triggering the stress response system, releasing adrenaline and cortisol to mobilize stored energy at the cost of a later crash. Supporting mitochondrial efficiency means the cells themselves produce more ATP from the same fuel, without the hormonal stress response or the crash that follows it.

What the research shows

The fatigue reversal study. A 2012 study by Surapaneni et al. in the Journal of Ethnopharmacology modeled chronic fatigue syndrome in rats using repeated forced-swim stress. Shilajit reversed the behavioral fatigue the protocol induced, preserved mitochondrial enzyme activity in the affected tissues, and prevented the loss of mitochondrial membrane potential that occurred in the untreated group. Mitochondrial membrane potential is the electrical gradient across the inner mitochondrial membrane that drives ATP synthesis. Preserving it means preserving the cell's capacity to generate energy under sustained stress. (PMID 22771318. https://pubmed.ncbi.nlm.nih.gov/22771318/)

This is animal research, and animal fatigue models do not map perfectly to the lived experience of postmenopausal fatigue. But the mechanism it demonstrated, shilajit maintaining mitochondrial infrastructure under sustained oxidative stress, is directly relevant.

The muscle strength trial. An 8-week randomized controlled trial by Keller et al. (2019) enrolled 63 adults and measured muscle performance after a standardized fatigue protocol. The shilajit group preserved maximum muscle strength after fatigue better than the placebo group, and also showed lower levels of hydroxyproline, a marker of collagen breakdown in muscle tissue. The trial population was men, which is a genuine limitation for conclusions about postmenopausal women. The mechanism, preserving contractile muscle function under fatigue load, translates across sexes because mitochondrial function and collagen integrity are not sex-specific processes. (PMID 30728074. https://pubmed.ncbi.nlm.nih.gov/30728074/)

The gene expression study. An 8-week human trial by Das et al. (2016) gave 500 mg per day of shilajit to 16 healthy adults and took muscle biopsies before and after. The analysis found 17 genes in the extracellular matrix cluster significantly upregulated after supplementation. Collagen genes showed some of the largest changes. COL3A1 increased by 5.18 times and COL1A2 increased by 5.13 times compared to baseline. These are the structural proteins that form the scaffolding of muscle tissue. Stronger scaffolding means better force transmission and faster recovery from effort. This is not an energy study in the direct sense, but it explains part of why physical effort may feel less depleting after consistent shilajit supplementation. (PMID 27414521. https://pubmed.ncbi.nlm.nih.gov/27414521/)

The performance pilot. A 2026 open-label pilot by Yadav et al. gave 500 mg per day of shilajit resin to 25 healthy adults over 28 days and found improvements in leg-press strength, endurance, and aerobic capacity, alongside reductions in fatigue and inflammation markers. The study has meaningful limitations: it had no placebo group, the sample was small, and the population was men. It is a weak-evidence data point. What it adds is a set of outcome measures, aerobic capacity and fatigue markers measured together, that aligns with the mitochondrial mechanism. (PMID 41613504. https://pubmed.ncbi.nlm.nih.gov/41613504/)

Shilajit and the estrogen connection in energy

The energy decline of menopause runs through the same upstream mechanism as many of the other changes that accompany it. When estrogen signaling weakens, the cells that depend on that signal for their housekeeping functions, including mitochondrial biogenesis and repair, become less active. Cells accumulate older, less efficient mitochondria over time. The ATP output per cell drops not because the mitochondria disappeared, but because they aged without being replaced.

Shilajit is not a hormone. It does not replace estrogen. What the fulvic acid in it appears to do is support the body's own estrogen signaling pathway. Because estrogen receptors sit on mitochondria throughout the body, supporting that signaling mechanism has downstream effects on mitochondrial health. This is one reason the energy effects of shilajit, to the extent the research supports them, may be more stable than what a stimulant produces. A stimulant routes around the energy deficit by triggering the stress system. Supporting estrogen signaling and mitochondrial function addresses the deficit at a layer closer to its source.

It is also worth noting the breast cancer question, since anything connected to estrogen raises it for some readers. Shilajit is not a hormone and does not work like estrogen replacement. Research published in Nutrients found that shilajit inhibited MCF-7 and MDA-MB-231 breast cancer cells and induced apoptosis while leaving normal breast cells unharmed. (PMID 34466597. https://pubmed.ncbi.nlm.nih.gov/34466597/) MCF-7 is the estrogen-receptor-positive breast cancer cell line. The concern about estrogen and estrogen-sensitive cancers applies to synthetic estrogen, not to compounds that support the body's own signaling.

Why the stimulant distinction matters for postmenopausal women

Women in midlife are often offered stimulant solutions for menopausal fatigue: more caffeine, energy drinks, pre-workout supplements with high-dose B vitamins and caffeine cocktails. These provide short-term relief. The cost is real.

Stimulants work by triggering a cortisol and adrenaline release, which mobilizes stored energy reserves. The crash that follows is the energy debt coming due. For postmenopausal women whose adrenal and cortisol systems are often already under pressure from the hormonal transitions of this period, adding more stimulant load tends to worsen the underlying depletion over time even as it provides temporary relief.

Shilajit does not trigger that cascade. The energy support the research points to comes from better mitochondrial efficiency, more stable ATP output, and improved muscle tissue integrity. There is no cortisol spike, no adrenaline release, and no afternoon crash to manage.

The honest picture on what is known

The mitochondrial case for shilajit in menopause-related fatigue is mechanistically solid and consistent with the animal research. The human evidence has meaningful gaps. The strongest muscle performance trial was conducted in men. The fatigue reversal research is in an animal model. There is not yet a large, randomized, placebo-controlled trial in postmenopausal women with fatigue as the primary endpoint.

What exists is a coherent mechanism backed by animal research, supported by human studies in adjacent populations, with a safety record that spans decades of traditional use and multiple modern clinical trials. The evidence is enough to make shilajit worth understanding as a serious option. It is not enough to make extravagant claims about it.

Safety

Zero serious adverse events have ever been reported across any human shilajit study.

A 91-day rat safety study tested shilajit at doses up to 5000 mg per kilogram of body weight and found no organ toxicity, stable iron levels, and normal tissue histology across liver, kidney, and other organs. (https://pmc.ncbi.nlm.nih.gov/articles/PMC3609271/) A review by Stohs et al. (2014) across the human and animal literature classified shilajit as generally well tolerated, with antioxidant, anti-inflammatory, adaptogenic, and ATP-enhancing effects consistently identified. (PMID 23733436. https://pubmed.ncbi.nlm.nih.gov/23733436/)

The main safety consideration in a commercial product is heavy metal content. Shilajit forms inside rock and can carry geological contaminants from the source region if it is not properly processed. Independent third-party lab testing for heavy metals and mycotoxins, with a certificate of analysis you can review, is not optional for a product you will take consistently.

What this means for you

The fatigue of menopause is mitochondrial in origin. Estrogen decline weakens the signals that keep mitochondria healthy and productive. Cells produce less ATP per unit of fuel. The depletion that follows is the particular exhaustion women in menopause describe, and it is different from the tired that more sleep fixes.

The shilajit research points toward a mechanism that addresses this at the cellular level. Not by triggering the stress system, not by masking the fatigue with stimulants, but by supporting the electron carriers and mitochondrial infrastructure that ATP synthesis depends on.

The evidence is still building. The strongest data comes from animal models and from trials in men. But the mechanism is sound, the safety record is excellent, and the absence of stimulant-driven side effects makes shilajit a researched option worth taking seriously for the energy question in the postmenopausal years.

Optimum Shilajit Trifecta combines purified shilajit from the Altai mountains with pearl powder and bamboo silica. Independently third-party lab tested for heavy metals and mycotoxins, with results on the website. A family-owned company out of Florida. They do not sell on Amazon and do not wholesale.

Frequently asked questions

Does shilajit actually give you energy?

The research supports improvement in mitochondrial function and ATP production efficiency. Clinical studies found better muscle strength preservation after fatigue, reversal of fatigue markers in a chronic fatigue model, and significant upregulation of muscle tissue genes. This is cellular energy support, not a stimulant effect.

Is shilajit a stimulant?

No. It contains no caffeine and does not trigger the adrenal response stimulants do. The mechanism is support for mitochondrial electron carriers, specifically stabilizing CoQ10 in its active form. No cortisol spike, no crash.

Why does menopause cause this kind of fatigue?

Estrogen supports the creation of new mitochondria and protects existing ones from oxidative damage. When estrogen signaling drops at menopause, mitochondrial function drops with it, reducing ATP output per cell. The fatigue women describe as different from anything before menopause is this: not sleep debt, but cellular energy production declining.

How long before there is a noticeable difference?

The human trials that measured muscle performance and energy markers ran 8 to 12 weeks. The mitochondrial changes the research identified are not immediate. Consistency over several weeks matters more than any single day's dose.

Is it safe to take long-term?

The safety record across published human trials is excellent. Zero serious adverse events have been reported. Long-term animal safety studies at doses far exceeding human supplementation found no organ toxicity. Product quality is the main consideration: independent third-party lab testing for heavy metals and mycotoxins is essential for any shilajit you take consistently.

References

1. Surapaneni D et al. Shilajit attenuates behavioral symptoms of chronic fatigue syndrome and preserves mitochondrial function in rats. Journal of Ethnopharmacology, 2012. PMID 22771318. https://pubmed.ncbi.nlm.nih.gov/22771318/
2. Keller J et al. "The effects of Shilajit supplementation on fatigue-induced decreases in muscular strength and serum hydroxyproline levels." Journal of the International Society of Sports Nutrition, 2019. PMID 30728074. https://pubmed.ncbi.nlm.nih.gov/30728074/
3. Das A et al. "A human pilot study of the effects of Shilajit supplementation on skeletal muscle transcriptome." Journal of Medicinal Food, 2016. PMID 27414521. https://pubmed.ncbi.nlm.nih.gov/27414521/
4. Yadav B et al. Shilajit supplementation and physical performance in healthy men: an open-label pilot. Phytomedicine Plus, 2026. PMID 41613504. https://pubmed.ncbi.nlm.nih.gov/41613504/
5. Velmurugan C et al. Subacute and subchronic oral toxicity of black Shilajit in rats. Ayu, 2012. https://pmc.ncbi.nlm.nih.gov/articles/PMC3609271/
6. Stohs S et al. "Safety and efficacy of Shilajit." Phytotherapy Research, 2014. PMID 23733436. https://pubmed.ncbi.nlm.nih.gov/23733436/
7. Rahmani Barouji S et al. Shilajit inhibition of MCF-7 and MDA-MB-231 breast cancer cells. Nutrients, 2020. PMID 34466597. https://pubmed.ncbi.nlm.nih.gov/34466597/